HomeAC6 • FRA
add
AlzeCure Pharma AB
Previous close
€0.099
Day range
€0.087 - €0.087
Year range
€0.047 - €0.26
Market cap
124.07M SEK
Avg Volume
1.61K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.78M | -2.10% |
Net income | -7.45M | 2.72% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -7.72M | 1.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 39.19M | 4.61% |
Total assets | 42.56M | 5.34% |
Total liabilities | 7.04M | 2.53% |
Total equity | 35.52M | — |
Shares outstanding | 88.30M | — |
Price to book | 0.25 | — |
Return on assets | -43.34% | — |
Return on capital | -51.98% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -7.45M | 2.72% |
Cash from operations | -8.32M | -7.03% |
Cash from investing | — | — |
Cash from financing | 3.59M | — |
Net change in cash | -4.73M | 39.15% |
Free cash flow | -5.74M | -12.76% |
About
Founded
2012
Website
Employees
11
